Terms: = Skin cancer AND MAF, MGC71685, 4094, ENSG00000178573 AND Treatment
6 results:
1. Development of a Macrophage-Related Risk Model for Metastatic Melanoma.
Li Z; Zhang X; Jin Q; Zhang Q; Yue Q; Fujimoto M; Jin G
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762054
[TBL] [Abstract] [Full Text] [Related]
2. Targeting Melanoma-Associated Fibroblasts (mafs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model.
Hajdara A; Çakır U; Érsek B; Silló P; Széky B; Barna G; Faqi S; Gyöngy M; Kárpáti S; Németh K; Mayer B
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629075
[TBL] [Abstract] [Full Text] [Related]
3. Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor.
Mattila KE; Mäkelä S; Kytölä S; Andersson E; Vihinen P; Ramadan S; Skyttä T; Tiainen L; Vuoristo MS; Tyynelä-Korhonen K; Koivunen J; Kohtamäki L; Aittomäki K; Hernberg M
Acta Oncol; 2022 Oct; 61(10):1263-1267. PubMed ID: 36307938
[TBL] [Abstract] [Full Text] [Related]
4. Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience.
Boccaccino A; Borelli B; Intini R; Antista M; Bensi M; Rossini D; Passardi A; Tamberi S; Giampieri R; Antonuzzo L; Noto L; Roviello G; Zichi C; Salati M; Puccini A; Noto C; Parisi A; Rihawi K; Persano M; Crespi V; Libertini M; Giordano M; Moretto R; Lonardi S; Cremolini C
ESMO Open; 2022 Jun; 7(3):100506. PubMed ID: 35696748
[TBL] [Abstract] [Full Text] [Related]
5. Immune Checkpoints Inhibitors and SRS/SBRT Synergy in Metastatic Non-Small-Cell Lung cancer and Melanoma: A Systematic Review.
Rodríguez Plá M; Dualde Beltrán D; Ferrer Albiach E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769050
[No Abstract] [Full Text] [Related]
6. Phase I clinical trial of an maf-containing lymphoblastoid cell line supernatant.
Reynolds RD; McEntire JE; Rodes ND; Dunn PA; Walter J; Doyle MK; Anson NO; Garcia A; Oxenhandler RW; Khojasteh A
J Biol Response Mod; 1986 Apr; 5(2):129-39. PubMed ID: 3525761
[TBL] [Abstract] [Full Text] [Related]